Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine K
ClinicalTrials.gov study NCT07091019. IPD Sharing: NO. Countries: 0. Publications: 0.
Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML
ClinicalTrials.gov study NCT06724536. IPD Sharing: NO. Countries: 1. Publications: 0.
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
ClinicalTrials.gov study NCT00003407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
ClinicalTrials.gov study NCT01761890. IPD Sharing: NO. Countries: 1. Publications: 0.
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT04605211. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
ClinicalTrials.gov study NCT02973711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
ClinicalTrials.gov study NCT03459534. IPD Sharing: NO. Countries: 4. Publications: 0.
Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT00038597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
ClinicalTrials.gov study NCT01901666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
ClinicalTrials.gov study NCT06453902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Modification Based on Early Assessment of CML Patients
ClinicalTrials.gov study NCT01762969. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
ClinicalTrials.gov study NCT03647215. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Early Conversion of Dasatinib in CML-CP Patients
ClinicalTrials.gov study NCT04136015. IPD Sharing: YES. Countries: 1. Publications: 0.
To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission
ClinicalTrials.gov study NCT03062436. IPD Sharing: NO. Countries: 1. Publications: 0.
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuatio
ClinicalTrials.gov study NCT04838041. IPD Sharing: NO. Countries: 1. Publications: 0.
Alternative splicing and the epigenome in CML remission [RNA-Seq]
GEO Series GSE144119. Homo sapiens. 97 samples. Type: Expression profiling by high throughput sequencing.
Gene expression changes associated with progression of Irf8–/– CML-like disease into blast crisis after β-catenin activation
GEO Series GSE49054. Mus musculus. 11 samples. Type: Expression profiling by array.
Metabolic alterations mediated by STAT3 promotes drug persistence in CML [HSC Bulk RNA-seq]
GEO Series GSE152706. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
Fubp1 knockdown in BCR-ABL1 induced chronic myeloid leukemia (CML) like myeloproliferative neoplasm mouse model
GEO Series GSE124304. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
Metabolic alterations mediated by STAT3 promotes drug persistence in CML [K562 bulk RNA-Seq]
GEO Series GSE174800. Homo sapiens. 11 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.